Codiak BioSciences Inc. (CDAK): Price and Financial Metrics
CDAK Price/Volume Stats
| Current price | $0.06 | 52-week high | $6.98 |
| Prev. close | $0.13 | 52-week low | $0.05 |
| Day low | $0.05 | Volume | 14,634,700 |
| Day high | $0.11 | Avg. volume | 1,366,845 |
| 50-day MA | $0.54 | Dividend yield | N/A |
| 200-day MA | $1.21 | Market Cap | 2.10M |
CDAK Stock Price Chart Interactive Chart >
Codiak BioSciences Inc. (CDAK) Company Bio
Codiak BioSciences, Inc. engages in the development and manufacturing of exosomes. It engages in harnessing exosomes, therapeutic applications, diagnostic applications, and proprietary production. The firm develops engEx Platform, a proprietary and versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. The company was founded by Douglas E. William, Raghu Kalluri, and Eric S. Lander in 2015 and is headquartered in Cambridge, MA.
CDAK Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -97.86% |
| 5-year | N/A |
| YTD | N/A |
| 2024 | N/A |
| 2023 | 0.00% |
| 2022 | -96.43% |
| 2021 | -65.51% |
| 2020 | N/A |
Loading social stream, please wait...